RVNC
Revance Therapeutics Inc
Price:  
3.61 
USD
Volume:  
1,896,957.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Stock Forecast & Price Target

RVNC Stock Price Forecast

The average stock forecast for Revance Therapeutics Inc (RVNC) in the next 12 months is 9.13 USD. This price target corresponds to an upside of 152.81%. The range of stock forecasts for RVNC is 6.06 - 26.25 USD. Based on the ratings of 16 analysts, the consensus recommendation for RVNC is HOLD.
Target Low Average Median High
Price (USD) 6.06 9.13 6.79 26.25
Upside 67.87% 152.81% 88.18% 627.15%

Recommendation Trends

The latest consensus rating for RVNC is "HOLD". This is the average recommendation of 16 analysts: 0 strong sell, 0 sell, 10 hold, 4 buy, 2 strong buy. In the previous period, 16 analysts also majorly recommmended "HOLD" for RVNC.

RVNC Financial Stock Forecast

Revenue This Year
257.01M
9.81%
from 234.04M
Revenue Next Year
335.78M
30.65%
from 257.01M
EPS This Year
-1.55
-49.75%
from -3.09
EPS Next Year
-1.06
-32.00%
from -1.55